发明名称 |
Sparstolonin B based pharmaceutical agent for neuroblastoma treatment |
摘要 |
Use of sparstolonin B in inhibition of growth and/or viability of human neuroblastoma cells is described. The sparstolonin B can be naturally derived from the Chinese herb Sparganium stoloniferum or can be synthetic. The sparstolonin B is shown to be effective both in vitro and in vivo in inhibition of growth and/or viability of neuroblastoma cells of multiple different genetic backgrounds including N-myc amplified with wild p53 neuroblastoma cells, N-myc amplified with mutated p53 neuroblastoma cells, and N-myc nonamplified neuroblastoma cells. |
申请公布号 |
US9446019(B2) |
申请公布日期 |
2016.09.20 |
申请号 |
US201414483445 |
申请日期 |
2014.09.11 |
申请人 |
University of South Carolina |
发明人 |
Kumar Ambrish;Singh Ugra Sen;Fan Daping;Dipette Donald J. |
分类号 |
A01N43/16;A61K31/35;A61K31/353;A61K31/37 |
主分类号 |
A01N43/16 |
代理机构 |
Dority & Manning, P.A. |
代理人 |
Dority & Manning, P.A. |
主权项 |
1. A method for inhibiting the viability of neuroblastoma cells in vitro, the method comprising contacting a neuroblastoma cell culture with sparstolonin B, wherein the sparstolonin B contacts the cells at a concentration of about 10 micromolar or greater, wherein upon contact, the neuroblastoma cells exhibit cell death. |
地址 |
Columbia SC US |